搜索临床试验以:GES(吉西他滨、厄洛替尼、S-1)
总计1231个结果
-
GlaxoSmithKline完全的
-
Japan Clinical Cancer Research OrganizationKorean Cancer Study Group完全的
-
National Cancer Center, KoreaJeil Pharmaceutical Co., Ltd.未知
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
Kazuhiko YoshimatsuHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Asan Medical CenterNational Cancer Center, Korea; Chonbuk National University Hospital; Samsung Medical Center; Chonnam... 和其他合作者完全的
-
Eastern Network of Cancer Immunological Therapy...终止
-
Quantum Genomics SA完全的
-
Cancer Institute and Hospital, Chinese Academy...完全的
-
National Institutes of Health Clinical Center (CC)完全的
-
TTY BiopharmNational Taiwan University Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital... 和其他合作者完全的
-
Tianjin Medical University Cancer Institute and...招聘中
-
Samsung Medical Center终止第一阶段:确定最大耐受剂量 (MTD) | II 期:评估 S1/奥沙利铂新辅助放化疗后的病理 CR 率和可行性大韩民国
-
AstraZeneca招聘中
-
The University of Hong KongLondon School of Hygiene and Tropical Medicine; Nagasaki University邀请报名
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Celgene Corporation完全的